vaccine efficacy

Search documents
“We’re going to see an explosion in diseases”: Doctor slams FL vaccine rollback
MSNBC· 2025-09-04 20:02
Vaccine Mandates & Public Health - Vaccine mandates and vaccination campaigns have historically been crucial in preventing diseases like diphtheria, polio, and measles, significantly reducing childhood mortality [2] - Government intervention, similar to regulations on substances like cocaine and heroin, is justified in protecting public health through vaccination [3][4] - Undermining established vaccination practices could lead to a resurgence of eradicated diseases, posing a significant public health risk [4] Politicization & Misinformation - COVID-19 vaccine safety and efficacy are being conflated with those of other long-established vaccines, creating confusion and distrust [5] - Influencers and non-medical professionals are spreading misinformation about vaccines, potentially harming public health [5] - Disregard for scientific consensus on vaccines, whether due to ignorance, stupidity, or malice, can have detrimental consequences for individuals and communities [6] Individual Choice vs Public Safety - The debate centers on individual autonomy in making health decisions versus the government's responsibility to protect its citizens [1][4] - The government's role is to protect the people, which is why they have laws [4]
‘Why would he do something so incredibly irresponsible?’ Doctor slams RFK Jr.
MSNBC· 2025-09-02 18:45
Vaccine Efficacy and Impact - Vaccines in 2021 were shown to reduce the likelihood of hospitalization and death by a factor of 12 compared to being unvaccinated [2] - Vaccines are estimated to have saved between 2 million and 3 million American lives [2] - Approximately 200,000 to 250,000 individuals who chose not to get vaccinated may have faced fatal consequences [3] - The primary goal of the COVID vaccine is to prevent serious illness, including hospitalization, ICU admission, and death, rather than preventing mild or moderate illness [5] Concerns Regarding Vaccine Availability and Public Perception - There are concerns that manufacturers like Eli Lilly and Pfizer may face production impacts [3] - The current Secretary of Health and Human Services is viewed as an antivaccine activist, potentially impacting vaccine availability, affordability, and public trust [4] - The Secretary of Health and Human Services has been accused of making false statements about the measles vaccine, including claims that it causes deaths, blindness, and deafness [7] - The removal of 17 members from the advisory committee of humanization practices and their replacement with less experienced individuals raises concerns about the quality of information from the ACIP and CDC [9] Alternative Information Sources - Due to concerns about information from the ACIP and CDC, people are turning to the American Academy of Pediatrics and the American College of Obstetrics and Gynecology for reliable vaccine information [10]
Invivyd Files Citizen Petition Urging FDA to Focus on Monoclonal Antibodies For Endemic-Virus-Era COVID-19 Prevention, and to Re-Assess COVID-19 Vaccine Efficacy
GlobeNewswire News Room· 2025-05-14 11:01
Core Viewpoint - Invivyd, Inc. has submitted a Citizen Petition to the FDA advocating for a shift in the development approach for COVID-19 vaccines and monoclonal antibodies to restore public trust and enhance the effectiveness of preventive measures against COVID-19 and other viral diseases [1][6]. Group 1: Changes in Immunity and Virus Evolution - The immunological landscape in the U.S. has changed significantly since 2020, with most Americans now having some level of immunologic memory due to vaccinations or infections [2]. - The SARS-CoV-2 virus has evolved from the original Wuhan strain to more immune-evasive Omicron variants, leading to reduced vaccine efficacy against these newer strains [3]. Group 2: Vaccine Efficacy and Clinical Trials - There is a better understanding of the rapid waning of vaccine efficacy, necessitating long-term clinical evaluations rather than short-term studies [4]. - Invivyd's petition calls for new clinical trials to assess COVID-19 vaccines in a modern U.S. population, including seropositive individuals, and against contemporary Omicron variants, with efficacy measured over six months or longer [6]. Group 3: Monoclonal Antibodies and Regulatory Recommendations - Invivyd emphasizes the importance of developing non-vaccine solutions, such as monoclonal antibodies, to provide high-quality alternatives for the American population [6]. - The petition recommends that the FDA consider serum virus neutralizing antibody (sVNA) titers as a basis for Biologics License Application (BLA) approval, which would benefit patients and healthcare providers [7]. Group 4: Company Overview - Invivyd, Inc. is focused on delivering protection against serious viral infectious diseases, starting with SARS-CoV-2, and has received emergency use authorization for a monoclonal antibody from the FDA [8].